Abnormal proinflammatory and stressor environmental with increased the regulatory cellular IGF-1/PAPP-A/STC and Wnt-1/β-Catenin canonical pathway in placenta of women with Chronic venous Disease during Pregnancy

• Published in: International journal of medical sciences Vol. 18; no. 13; pp. 2814 - 2827
• Main Authors: Ortega, Miguel A, Fraile-Martínez, Oscar, Saez, Miguel A, Álvarez-Mon, Miguel A, Gómez-Lahoz, Ana M, Bravo, Coral, Luis, Juan A De León, Sainz, Felipe, Coca, Santiago, Asúnsolo, Ángel, Monserrat, Jorge, Guijarro, Luis G, Álvarez-Mon, Melchor, Bujan, Julia, García-Honduvilla, Natalio
• Format: Journal Article
• Language: English
• Published: Wyoming Ivyspring International Publisher Pty Ltd 01.01.2021; Ivyspring International Publisher
• Subjects: Antibiotics; Antigens; Gene expression; Insulin-like growth factors; Laboratories; Pathogenesis; Placenta; Preeclampsia; Pregnancy; Protein expression; Proteins; Research Paper; Statistical analysis; Womens health; United States > US; Massachusetts
• ISSN: 1449-1907; 1449-1907
• DOI: 10.7150/ijms.58992

Lower limbs venous insufficiency refers to a wide variety of venous disorders grouped by the term of chronic venous disease (CVD). Hemodynamic and hormonal changes related to pregnancy period, may promote the development of CVD affecting approximately 1 in 3 women. It has been shown that the presence of this condition is associated with damage and placental suffering. Thus, taking IGF-1/PAPP-A/STC-2, inflammatory cytokines production, PI3K/Akt and Wnt/ β-catenin pathways as a part of the alterations that occurs in the placenta due to CVD, the aim of this study will be to examine the main components of these pathways. Genic and protein expression of PAPP-A, STC-2, IGF-1, IRS-4 Wnt-1, β-catenin, c-myc, Cyclin D1, IL-4/IL-6 and PI3K/Akt/mTOR pathway will be analysed through RT-qPCR and immunohistochemical techniques in women with CVD (n=62) and pregnant women without this condition (HC) (n=52). PAPP-A, IGF-1, IL-4, IL-6, IRS-4, PI3K, Akt, mTOR, Wnt-1, β-catenin, c-myc and Cyclin D1 expression were found to be increased in women with CVD, whereas STC-2 were decreased in this group, compared to non-affected women. Our study has demonstrated that IGF-1/PAPP-A/STC-2 axis, PI3K/Akt and Wnt/β-catenin pathways, along with c-myc, Cyclin D1 and inflammatory cytokines are altered in placenta women with CVD. These results extent the knowledge that CVD is associated to a placenta damage with abnormal tissue environment and cellular regulation.